lobbying_activities: 2504264

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2504264	6898294b-9de9-44a6-8fbd-44ffc418c4ce	Q3	TODD STRATEGY GROUP	401103321	BIODESIX, INC.	2020	third_quarter	MMM	Implementation of changes to Medicare payments for clinical laboratory tests. Medicare treatment of outpatient reimbursement for laboratory tests. FDA regulation of laboratory developed tests (LDTs).	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2020-10-06T11:50:16.917000-04:00